304 related articles for article (PubMed ID: 22281286)
1. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
Villoslada P; Baranzini S
J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for multiple sclerosis.
Villoslada P
Drug News Perspect; 2010 Nov; 23(9):585-95. PubMed ID: 21152453
[TBL] [Abstract][Full Text] [Related]
3. The future: biomarkers, biosensors, neuroinformatics, and e-neuropsychiatry.
Lowe CR
Int Rev Neurobiol; 2011; 101():375-400. PubMed ID: 22050860
[TBL] [Abstract][Full Text] [Related]
4. From bench to MS bedside: challenges translating biomarker discovery to clinical practice.
Rajasekharan S; Bar-Or A;
J Neuroimmunol; 2012 Jul; 248(1-2):66-72. PubMed ID: 22381245
[TBL] [Abstract][Full Text] [Related]
5. Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis.
Baranzini SE
Autoimmunity; 2006 Dec; 39(8):651-62. PubMed ID: 17178562
[TBL] [Abstract][Full Text] [Related]
6. Proteomics technologies for biomarker discovery in multiple sclerosis.
Singh V; Hintzen RQ; Luider TM; Stoop MP
J Neuroimmunol; 2012 Jul; 248(1-2):40-7. PubMed ID: 22129845
[TBL] [Abstract][Full Text] [Related]
7. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
8. From -omics to personalized medicine in nephrology: integration is the key.
Pesce F; Pathan S; Schena FP
Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
[TBL] [Abstract][Full Text] [Related]
9. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
Baudhuin LM; Donato LJ; Uphoff TS
Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.
Csanky E; Olivova P; Rajnavolgyi E; Hempel W; Tardieu N; Katalin ET; Jullien A; Malderez-Bloes C; Kuras M; Duval MX; Nagy L; Scholtz B; Hancock W; Karger B; Guttman A; Takacs L
Electrophoresis; 2007 Dec; 28(23):4401-6. PubMed ID: 18041035
[TBL] [Abstract][Full Text] [Related]
11. Computational biology for cardiovascular biomarker discovery.
Azuaje F; Devaux Y; Wagner D
Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
[TBL] [Abstract][Full Text] [Related]
12. Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Dagley LF; Emili A; Purcell AW
Proteomics Clin Appl; 2013 Jan; 7(1-2):91-108. PubMed ID: 23112123
[TBL] [Abstract][Full Text] [Related]
13. Biomarker discovery and validation: technologies and integrative approaches.
Ilyin SE; Belkowski SM; Plata-Salamán CR
Trends Biotechnol; 2004 Aug; 22(8):411-6. PubMed ID: 15283986
[TBL] [Abstract][Full Text] [Related]
14. What do 'omic technologies have to offer periodontal clinical practice in the future?
Grant MM
J Periodontal Res; 2012 Feb; 47(1):2-14. PubMed ID: 21679186
[TBL] [Abstract][Full Text] [Related]
15. Systems medicine and metabolic modelling.
Mardinoglu A; Nielsen J
J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
[TBL] [Abstract][Full Text] [Related]
16. Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine.
van der Greef J; van Wietmarschen H; Schroën J; Wang M; Hankemeier T; Xu G
Planta Med; 2010 Dec; 76(17):2036-47. PubMed ID: 20979015
[TBL] [Abstract][Full Text] [Related]
17. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
18. The road from systems biology to systems medicine.
Wolkenhauer O; Auffray C; Jaster R; Steinhoff G; Dammann O
Pediatr Res; 2013 Apr; 73(4 Pt 2):502-7. PubMed ID: 23314297
[TBL] [Abstract][Full Text] [Related]
19. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
20. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
